Antonio Crisafulli is a Cardiovascular Physiologist. He leads the Laboratory of Sport Physiology of the University of Cagliari (Italy). He teaches Human Physiology at the Faculty of Medicine of the University of Cagliari. His fields of research are exercise cardiovascular physiology and physio-pathology, assessment of physical capacity and cardiovascular response during exercise in healthy and in patients suffering from cardiovascular and metabolic diseases. He has published more than 70 papers in this area.
Dr. Huang is the Director of Cardiovascular Research Institute of Wuhan University, Professor of Cardiology (second-grade) and Chief physician (first-grade) of Renmin Hospital of Wuhan University, Director of Hubei Key Laboratory of Cardiology, Hubei Cardiovascular Clinical Research Center, and Hubei Cardiovascular Interventional Diagnosis and Treatment Quality Control Center. He is also the Vice President of the National Cardiovascular Disease Expert Committee, and President of the Chinese Society of Pacing and Electrophysiology. He also holds the position of Editor-in-Chief of the Chinese Journal of Cardiac Pacing and Electrophysiology, and the Medical Journal of Wuhan University, Vice Editor-in-Chief of the International Journal of Heart Rhythm, Journal of Cardiovascular Electrophysiology (Chinese edition), and Chinese Journal of Cardiac Arrhythmias and also involved in the Editorial Board Member of Chinese Journal of Cardiology.
Michail I. Papafaklis, M.D., Ph.D., FESC is a licensed Cardiologist both in Greece and the United Kingdom (GMC Specialist Register). He has been trained in Interventional Cardiology at Barts Heart Centre, St Bartholomew's Hospital in London, UK, and is certified by the European Association of Percutaneous Coronary Intervention (EAPCI). Dr Papafaklis is a leading researcher in cardiovascular medicine. He has received distinguished research awards from the European Society of Cardiology, Academy of Athens, Hellenic Harvard Foundation and the Hellenic Heart Foundation. His research interests focus on percutaneous coronary interventions, hemodynamics, invasive and non-invasive three-dimensional imaging of coronary arteries, biomedical engineering in the cardiovascular system, and the pathophysiology and molecular mechanisms of atherosclerosis.
Dr. Cesaro is an Assistant Professor at University of Campania “L. Vanvitelli”. He does research in cardiology with a focus on the management of patients with acute and chronic coronary syndrome undergoing percutaneous coronary intervention. He has a specific interest in lipid-lowering therapies and anti-thrombotic pharmacotherapies. His research activity also involves genetic dyslipidemia with a particular interest in familial hypercholesterolemia (HeFH and HoFH) and new therapeutic strategies.
Prof. Ertan Yetkin, is currently working at Istinye University Liv Hospital Dept. of Cardiology, in Istanbul, Turkey. Prof. Yetkin received his medical degree from the Hacettepe University Faculty of Medicine in Turkey in 1994. He afterwards completed his residency training at Turkiye Yuksek Ihtisas Hospital Department of Cardiology in 1999. Dr Yetkin worked as a research scientist in the Dept. of Cardiology at the Maastricht University Medical Center, at the Cardiovascular Research Institute Maastricht (CARIM), the Netherlands in 2006-2007. His research focuses on vascular biology, valvular heart disease and coagulation system. Dr Yetkin is a member of European Vascular Biology Organization and president of Society of Vascular and Molecular Cardiology. He has obtained 2 “Young investigator awards” from the European Society of Cardiology and published more than 200 scientific publications.
Dr. Ling-Bo Qian earned PhD from the Zhejiang University, China. He completed his visiting scholar at the University of Copenhagen, Denmark and University of Louisville, USA. He teaches human physiology at the School of Basic Medical Sciences & Forensic Medicine of Hangzhou Medical College, China. He has particular interests in diabetic cardiovascular complications, and for the past decade he has focused on the pathophysiology of diabetic myocardial ischemia/reperfusion injury and the protective strategy. He has published more than 30 peer-reviewed articles in cardiovascular diseases. He has reviewed more than 10 journals.
Dr. Kohsaka is a United States trained, board certified Cardiologist and currently serves as Senior Lecturer of Keio University School of Medicine (Division of Cardiology) and Visiting Researcher of the Tokyo University Graduate School of Medicine in Tokyo, Japan. He has specialized in coronary artery disease, advanced heart failure, preventive cardiology, outcome and quality research in cardiovascular care. He has received a number of awards for his contribution in Cardiology.
Dr. Kuller received his BA degree in 1955 from Hamilton College in Clinton, NY, his MD in 1959 from George Washington University School of Medicine, his MPH in 1964 and DrPH in 1966 from the Johns Hopkins University School of Public Health. He was a faculty member at the Johns Hopkins University School of Public Health. At the same time he was also a faculty member at the Department of Preventive Medicine at the University of Maryland School of Medicine. He was Chair and Professor in the Department of Epidemiology at the Graduate School of Public Health at the University of Pittsburgh from 1972-2002.
Harvey Weiss received his Ph.D. in Physiology from Duke University. He did postdoctoral training at Warner-Lambert and Columbia University. Dr. Weiss is currently a Professor at Rutgers Robert Wood Johnson Medical School. He is the author of over 325 peer reviewed papers. His research interests are in the control of regional and microregional oxygen supply/consumption balance in both the heart and brain. He has been interested in how alterations in signal transduction affect both local oxygen supply and consumption. Dr. Weiss has been Associate Editor for Microvascular Research and on the editorial boards of Microcirculation Endothelium and Lymphatics, American Journal of Physiology: Heart and Circulatory Physiology and the Journal of Cardiovascular Pharmacology as well as other journals.
Giuliano Tocci, specialized in Cardiology in 2006 and graduated in the PhD course in Angio-Cardio-Thoraco-Vascular Physiopathology in 2011, is currently Assistant Professor in Cardiology at the University of Rome Sapienza, Italy. He works as Clinical Cardiologist at the Sant’Andrea Hospital in Rome. He is Hypertension Specialist of the European Society of Hypertension. His main clinical interests address pathophysiological alterations and cardiovascular risk profile in patients with hypertension and heart failure. He has published more than 150 scientific publications on international journals, books and chapters in the field of hypertension and hypertension-related cardiovascular diseases.
Dr. Berti is the chief of the department of Diagnostic and Interventional Cardiology of the Hospital of Massa (Italy). He is currently regional member of the A.M.N.C.O. (National Association of Hospital Cardiological Medics) Council and Professor at the School of Cardiology (University of Florence). He advocates evidence-based medicine, and is experienced in interventional cardiology, covering from invasive imaging, endovascular treatment of Heart Valves and Left Atrial Appendage Closure. He is involved in several clinical studies, pharmaceutical (predominantly Phase III) as well as device-specific (both pre- and post-market).
Dr. Klein is Professor of Medicine, Rush Medical College, Chicago, Illinois and Director, Clinical Cardiology Associates, Chicago and Melrose Park, Illinois. He is a nationally recognized expert in individualizing coronary revascularization strategies. Dr. Klein is a pioneer in the objective assessment of quality assessment and case appropriateness in coronary interventions. He was on the steering committee of ASCERT. He is the author of over 500 publications and editor of four books. One of his proudest accomplishments is his significant involvement as a key faculty member in interventional, general cardiology and internal medicine training programs.
Dr. Dumaine graduated from University of Sherbrooke (Canada) in biophysics and pursued postdoctoral training at Balylor College of Medecine (TX) in cardiac electrophysiology and molecular genetics. He is now full professor at the department of Pharmacology and Physiology at the Univ. de Sherbrooke Qc. Canada. His expertise is on cardiac arrhythmias linked to potassium and sodium ion channel defects. In collaboration with P. Schwartz he published the first study linking sudden infant death syndrome (SIDS) to cardiac sodium channel defects.
Professor Shanahan obtained a PhD in Genetics from the University of Adelaide in Australia and did her postdoctoral training in Sydney Australia (CSIRO) and at the University of Cambridge UK (Departments of Biochemistry and Medicine). Currently she is the Chair of Cellular Signalling in the Cardiovascular Division at King’s College London. Professor Shanahan’s work focuses on mechanisms of vascular smooth muscle cell (VSMC) dysfunction in ageing and disease and she has published over 120 scientific papers.
Dr. Holmes is currently a Professor of Medicine at the Mayo Clinic College of Medicine and a consultant in the Department of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota. His special areas of interest include acute coronary syndromes, interventional cardiology, restenosis, vascular biology, and risk outcomes analysis. Finally, he is involved in the development of continued application of percutaneous coronary intervention technology to noncoronary vascular beds. Dr. Holmes received his medical degree at Medical College of Wisconsin in Milwaukee and completed his internship at Virginia Mason Hospital in Seattle. He also served in the United States Navy at the National Naval Medical Center in Bethesda.
Emeritus Prof. Masao Endoh is presently the Director of Japanese Northeast Region Health Examination Center, All Japan Laborer-Welfare Association after retirement from the Vice-President of Yamagata University and Dean of Yamagata University School of Medicine, Yamagata, Japan. He received his Medical Degree from the Tohoku University School of Medicine, Japan. He received Keith Reimer Distinguished Lecture award and Distinguished Leader award of the ISHR. He published over 220 papers in international journals of Cardiovascular Pharmacology and Physiology with peer review and is currently acting as an editorial board member of various international journals, including Circulation Research (Consulting Editor), Cardiovascular Research (Consulting Editor), Journal of Molecular and Cellular Cardiology (Associate Editor), and the Editorial board member of European Journal of Pharmacology and Journal of Cardiovascular Pharmacology.
Juan Jose Badimon, PhD, FACC, AHA is a professor of Medicine and director of the Atherothrombosis Research Unit, Cardiovascular Institute, Mount Sinai School of Medicine, New York. He has trained more than 30 fellows and published more than 360 peer-reviewed articles in cardiovascular diseases. He has reviewed more than 10 journals. He is Academico de Honor of the Spanish Royal Academy of Pharmacy and holds a Honoris Causa Professorship by the Catholic University of Buenos Aires and Honorary Memberships of the Cardiology societies of Spain, Argentina, Chile, Ecuador, Mexico, Peru and Venezuela.
Dr. Nakata obtained a medical doctor (MD) in 1983 and a doctorate (Ph.D.) in Medicine from the Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan. He was a visiting research fellow of Cardiovascular Research, the Rayne Institute, St Thomas’ Hospital, London. He is a specialist of Cardiology, Internal Medicine, Hypertension, Nuclear Medicine and PET imaging, all of which are certificated by each Japanese Society. Currently he is a hospital superintendent of Hakodate Goryoukaku Hospital, Hakodate, Japan, a clinical associate professor (Cardiology) of Sapporo Medical University School of Medicine, and a director of Japanese Society of Nuclear Cardiology. He has published more than 100 scientific publications. He is now the editorial member of Current Cardiology Review and Journal of Nuclear Cardiology.
Dr. Tong Liu was graduated from Tianjin Medical University, China in 2000, and got his PhD in 2006. He received training in the research of electrophysiology in the Heart Institute, Cedars-Sinai Medical Center, Los Angeles, from 2009 to 2010. He has particular interests in cardiac electrophysiology, and for the past decade he has focused on the research of atrial fibrillation. He is the Youth Committee Member of Chinese Society of Pacing and Electrophysiology (CSPE). He is on the editorial boards of World Journal of Cardiology, Cardiovascular Diagnosis and Therapy and Current Cardiology Reviews, and a peer reviewer for more than 35 scientific journals. He has published over 70 articles in peer reviewed medical journals.
Dr. Wenger is Professor of Medicine in the Division of Cardiology at the Emory University School of Medicine. She is a Consultant to the Emory Heart and Vascular Center. Coronary heart disease in women is one of Dr. Wenger’s major clinical and research interests. Dr. Wenger has participated as an author of several American College of Cardiology/American Heart Association Clinical Practice Guidelines. She is past Chair, Board of Directors, Society for Women’s Health Research. She is listed in Best Doctors in America. Dr. Wenger has authored or coauthored over 1600 scientific and review articles and book chapters.
Alan Daugherty completed a BSc in Pharmacology at Sunderland Polytechnic and received his PhD and DSc from the University of Bath. He moved to Washington University in St. Louis for fellowship training. Subsequently, he was appointed to the faculty at Washington University where he continued his studies on mechanisms of lipoprotein modification and immune function on the development of atherosclerosis. In 1997, he moved to the University of Kentucky. While performing a collaborative study with Lisa Cassis on the role of hypertension in development of atherosclerosis, they serendipitously developed a model of aortic aneurysms in both the abdominal and thoracic region. Alan Daugherty is the Linda and Jack Gill Professor of Preventive Cardiology, Director of the Saha Cardiovascular Research Center, Chair of the Department of Physiology, Senior Associate Dean for Research in the College of Medicine, and Associate Vice President for Research. He is the currently the Editor-in-Chief of Arteriosclerosis, Thrombosis, and Vascular Biology.
Dr. Doyle obtained his doctorate degree from the University of Nottingham, England in 1983. At Nottingham he studied under Nobel Laureate Sir Peter Mansfield, where he focused on rapid imaging. He is now an adjunct Professor of Medicine at Temple University, Philadelphia. He was a founding member of the Society of Cardiovascular Magnetic Resonance. His main research focus is on the application of Cardiovascular Magnetic Resonance Imaging to better understand and diagnose cardiovascular disease. He has over 50 publications and book chapters, including the CMR teaching book Cardiovascular MRI Tutorial: Lectures and Learning.
Dr. Santoro is a cardiologist, phD student at the university of Foggia Italy and consultant in Electrophysiology at Bonomo Hospital , Andria, Italy. In 2013, he attended for six months Texas Arrhythmia Institute, Austin, Texas, USA under the supervision of Dr. Andrea Natale. Between 2015 and 2018 he attended the electrophysiology laboratory at the Department of Cardiology, Asklepios Klinik St. Georg, Hamburg. Research topic: Cardiomyopathies (Takotsubo syndrome) and catheter ablation of Atrial Fibrillation and Ventricular Tachycardia (Papillary muscles VT/VF). He authored 138 publications in indexed journals, about 135 abstracts and 6 electrophysiology book chapters.
Prof. Mehta received his MD degree in India and PhD in Sweden, and completed his post-graduate education in New York and Minnesota. He joined the faculty of the college of medicine of the University of Florida where he rose to be University Research Foundation. He led the Division of Cardiovascular Medicine at UAMS until 2007. Prof. Mehta has lectured in over 30 countries. He is an honorary professor in the University of Rome, and adjunct Professor in the Clinton School of Public School in Little Rock, AR, and serves as consultant to the University of Arkansas in nanotechnology and biomedical engineering.
Dr. Sekikawa obtained an MD (Tohoku University, Japan) in 1983, a PhD in medicine (Yamagata University, Japan) in 1990, and his second PhD in Epidemiology (University of Pittsburgh, US) in 1999 and is currently as Associate Professor of Epidemiology, Graduate School of Public Health, University of Pittsburgh. Dr. Sekikawa has 30 years of experience in clinical and epidemiological research. His research interests lie on international cardiovascular epidemiology contrasting Japan to other developed countries, subclinical atherosclerosis including coronary artery calcification, intima-media thickness of the carotid artery and vascular stiff ness, as well as nutrition especially omega-3 fatty acids and isoflavones.
Prof. Erick Alexanderson is presently the President of the Mexican Society of Cardiology and Chairman of Nuclear Cardiology Department at the Instituto Nacional de Cardiología “Ignacio Chávez” and Chair Elect of International Governors ACC. He received his Medical Degree at the Faculty of Medicine of the National Autonomous University of Mexico (UNAM), with an average of 10, winning the Gabino Barreda Medal for Scholar Merit and inducted as member of the gallery of illustrious students of the Medicine Faculty. He is also winner of the SIBIC award for “Best Cardiology Resident”. He published 130 in Level III, IV and V Journals, with over 400 quotes. He was Principal author of 3 textbooks, author of 38 chapters.
Suowen Xu, Ph.D., is a natural product pharmacologist. Dr. Xu received his Ph.D. did postdoc studies in biochemistry at NHLBI/NIH, followed by a second postdoc in vascular biology at University of Rochester. Currently, Dr. Xu is Research Assistant Professor of Medicine at University of Rochester. He is a principal investigator interested in identifying novel therapeutic targets and molecular interventions of cardiovascular diseases. He was also an adjunct faculty member (Associate Professor) in the School of Pharmacy, The University of Queensland. He is an editorial board member of 4 journals and serves as reviewers for over 50 journals.
Dr. Ramin Rezaee is currently an Assistant professor at School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. He received Doctor of Pharmacy (PharmD) degree from Mashhad University of Medical Sciences, Iran in 2007 and PhD in Toxicology from Mashhad University of Medical Sciences, Iran in 2014. He has numerous publications to his credit.
Dr. Riccardo Proietti is a highly educated cardiac electrophysiologist who successfully completed his PhD in Cardiovascular Science in Italy followed by a Clinical Fellowship in Cardiac Electrophysiology in North America. He is extremely passionate in the field of research that has transpired in more than 60 publications in international peer-reviewed journals and two books. Dr. Proietti has around 10 years of experience in clinical practice (public hospitals in Italy), focusing on cardiac pacing and interventional electrophysiology. His Key skills include strong interpersonal communication with colleagues and students, an ability to follow through research projects, analytical thinking, and extensive experience in clinical practice.
Responsible for managing patients with pulmonary hypertension. It performs a major activity in echocardiography laboratories where transesophageal eco and ecostress are performed. Collaboration with the Cardiac Surgery Institute for intra and post-operative disorders with post-embolic, post-valve and related left ventricular dysfunction. Dr. Serra has collaboration with hemodynamics for the performance of cardiac catheterization in pulmonary hypertension, and collaboration with DH Cardiology for the management of patients with cardiomyopathy, pulmonary hypertension and severe heart failure. He has 72 publications in Italian and foreign journals. He did some presentations at national and international congresses such as ESC, AMNCO, SIEC and SIC. He belongs to various heart associations, such as AMNCO, SIC, SIEC,ESC, and ESC-HF.
Dr. Rajeev Gupta is a reviewer for Journal of American Heart association (JAHA), Annals of Internal Medicine, International Journal of Cardiology (IJC), Echocardiography Journal, American Journal of Cardiology, Heart, Lung and Circulation, World Heart Journal, Clinical Cardiology, Vascular, Heart and Lung: The journal of acute and critical care, Journal of patient experience, Saudi Medical Journal and the abstracts of ESC annual conferences, and had been honored as an excellent reviewer by the Annals of Internal Medicine in 2017, and by the Heart and Lung: The journal of acute and critical care (an official publication of the American Association of Heart Failure Nurses) in 2018. Associate Editor of World Heart Journal. Dr. Rajeev Gupta practices Cardiology, including coronary interventions at prestigious Mediclinic Hospital, Al Ain, UAE.
Dr. Abdelghani is a Consultant Cardiologist and a Lecturer of Cardiology at Al-Azhar University – Cairo, Egypt. He was awarded the PhD degree from The University of Amsterdam for his thesis entitled “Transcatheter Interventions for Structural Heart Diseases: Present and Future” and received his interventional cardiology training at the Heart Center, Segeberger Kliniken – Bad Segeberg, Germany. Dr. Abdelghani is a Professional Member of the European Society of Cardiology, The European Association of Percutaneous Cardiovascular Interventions, The ESC Working Group on Grown-Up Congenital Heart Disease, and the ESC Council on Valvular Heart Disease. He is currently a member of the Steering Committee of the Egyptian Transcatheter Valve Registry (Egy-TVR) and the Virtual CME Group of the Egyptian Society of Cardiology. Dr. Abdelghani has authored over 60 peer-reviewed publications and 5 book chapters, served as an Editorial Board member of EuroIntervention Journal from 03/2015 to 05/2020. He is a regular reviewer for nine cardiovascular medical journals.
Dr Eleonora Russo obtained a degree in Medicine and Surgery with a summa cum laude in 2006 at the Catholic University of the Sacred Heart. She completed her specialization in Cardiology with a summa cum laude in 2011 at the same university. Since 2009, she has attended EP lab at the Catholic University of the Sacred Heart. Dr. Russo, later joined Cardiac Arrhythmia Center at Centro Cardiologico Monzino as a fellow first, then as a cardiac electrophysiologist in EP Lab until 2017. In 2014, Dr. Russo received a PhD degree in physiopathology of heart failure at the Catholic University of the Sacred Heart. Currently, she is a cardiologist in the Cardiovascular Department at Casa Sollievo della Sofferenza IRCCS, Italy.
Dr. Arun Kanmanthareddy is currently an Assistant Professor of Medicine at the Creighton University School of Medicine in Omaha, Nebraska. He is an interventional cardiologist with specialization in structural heart disease and performs minimally invasive treatments for valvular and structural heart disease. His area of research interests includes valvular heart disease, coronary and peripheral vascular disease. He has earned his medical degree from Armed Forces Medical College, India.
Dr. Pupalan Lyngkaran is a qualified Cardiologist and subspecialist in Echocardiology, Cardiac Imaging Heart Failure at HeartWest, St Vincents and Western Private Hospital and he is currently serving as a Senior Lecturer at Flinders University (Northern Territory Medical School) and Notre Dame University (Melbourne Medical School). He has also won independent medical grants from government and private bodies for works in Cardiac Imaging and Heart failure. His research interests are aligned towards improving heart failure outcomes using epidemiological and imaging methods and he also collaborates with basic research in this areas.
Dr. Mohammad Alkhalil is currently an Interventional Fellow at the Toronto General Hospital, Toronto, Canada. He obtained his BSc Intercalation and MD Dissertation from the University of Damascus in 2003 and 2006, respectively. Later, he received MSc (Cardiology) from the Trinity College Dublin in 2012 and DPhil (Cardiovascular Medicine) from the University of Oxford in 2018. Apart from this, he received MRCP from the Royal College of Physicians of Edinburgh in 2009 and a Certificate of Completion of Specialist Training (CCST) from the Northern Ireland Deanery in 2020. Moreover, he has contributed his valuable publications in different scientific journals and has been awarded at various platforms for his outstanding contribution in his field.
Dr Uzoma N. Ibebuogu is currently an Associate Professor of Medicine at the Division of Cardiovascular diseases and an Associate Professor of Preventive Medicine at the College of Medicine, University of Tennessee Health Science Center. Dr Ibebuogu obtained his medical degree from the prestigious College of Medicine, University of Ibadan, Nigeria. He completed his Internal Medicine residency and Cardiology fellowship at the Medical College of Georgia in Augusta and subsequently underwent Interventional Cardiology fellowship and structural heart disease training at Cedars-Sinai Medical Center/the University of Los Angeles, California program. He has authored peer-reviewed articles on coronary atherosclerosis, which is one of his areas of interest, particularly in smokers and diabetic patients. His other research interests involve transcatheter aortic valve replacement therapies and ethnic disparities in the clinical presentation of acute myocardial infarction.